首页 | 本学科首页   官方微博 | 高级检索  
     

后程加速超分割放射治疗食管癌疗效荟萃分析
引用本文:邹长林,胡美龙. 后程加速超分割放射治疗食管癌疗效荟萃分析[J]. 中华放射肿瘤学杂志, 2001, 10(1): 18-20
作者姓名:邹长林  胡美龙
作者单位:浙江省温州医学院附属第一医院放射治疗科
摘    要:目的 评价后程加速超分割放射治疗食管癌疗效。方法 对6个后程加速超分割放射治疗食管癌临床试验进行Meta分析。结果 采用固定效应模型计算,后超组1、3年生存率分别是常规组的2.39(1.58~3.62)、3.05(1.96~4.74)倍;采用随机效应模型计算,后超组1、3年生存率分别是常规组的2.43(1.54~3.82)、2.99(2.08~4.30)倍。结论 后程加速超分割放射治疗食管癌优于常规分割放射治疗,值得在临床上推广应用。

关 键 词:食管肿瘤 放射疗法 后程加速超分割 放射治疗
修稿时间:2000-08-16

Meta-analysis of the effect of late course accelerated hyperfractionation radiotherapy for esophageal carcinoma
ZOU Changlin,HU Meilong. Deptpartment of Radiation Oncology,Wenzhou Medical College First Hospital,Wenzhou ,China. Meta-analysis of the effect of late course accelerated hyperfractionation radiotherapy for esophageal carcinoma[J]. Chinese Journal of Radiation Oncology, 2001, 10(1): 18-20
Authors:ZOU Changlin  HU Meilong. Deptpartment of Radiation Oncology  Wenzhou Medical College First Hospital  Wenzhou   China
Affiliation:ZOU Changlin,HU Meilong. Deptpartment of Radiation Oncology,Wenzhou Medical College First Hospital,Wenzhou 325000,China
Abstract:Objective To evaluate the effect of late course accelerated hyperfractionation radiotherapy(LCAHR) for esophageal carcinoma.  Methods Six clinical trials on LCAHR for esophageal carcinoma were reviewed by means of Meta-analysis .  Results The 1- and 3-year survival rates in the LCAHR group derived from the fixed effect model were 2.39 (1.58~3.62) and 3.05(1.96~4.74) times higher than the conventional fractionation group. With the random effect model,the 1- and 3-year survival rates in the LCAHR group were 2.43(1.54~3.82) and 2.99(2.08~4.30) times higher than the conventional fractionation group. Conclusion For esophageal carcinoma,the better outcome of LCAHR makes it advisable in extensive clinical practice.
Keywords:Esophageal neoplasms/radiotherapy  Accelerated hyperfractionation  Meta analysis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号